Kineta Announces TuHURA Biosciences Extends Exclusivity Agreement for KVA12123

TipRanksOct 2 16:15 ET

Express News | Kineta Announces the Extension of the Tuhura Biosciences Exclusivity and Right of First Offer Agreement for Kva12123, Kineta’s Vista Blocking Antibody Currently in Phase 1

ReutersOct 2 16:05 ET

News On Kineta Inc. (KA) Now Under KANT

Dow JonesSep 20 17:08 ET

Express News | Kineta Inc: Will Continue to Pursue Strategic Alternatives as Previously Announced

ReutersSep 19 18:25 ET

Express News | Kineta: Will Be Trading Under Symbol "Kant" on OTC Pink

ReutersSep 19 18:25 ET

Express News | Kineta, Inc Transitioning From Nasdaq to OTC Markets

ReutersSep 19 18:24 ET